Indefinite Delivery Contract 36E79725D0044

Award Date 10/3/25
Last Date to Order 10/2/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is to Golden State Medical Supply, Inc. (a for-profit manufacturer and distributor of pharmaceutical products) to provide Buspirone HCL tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a ceiling value of $16,423,902.10 and a period of performance from August 7, 2020 to August 6, 2025, with a base year and four one-year option periods. The contract was...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the supply of Clopidogrel Bisulfate tablets. The $15,979,579.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of April 14, 2026. The contract aims to provide an uninterrupted supply of Clopidogrel Bisulfate tablets in various bottle...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The single-award, $10,819,189.25 ceiling value contract is for the supply of various generic pharmaceutical products, including tablets and capsules containing gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER, naproxen, hydralazine, and celecoxib. The...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the provision of gabapentin tablets. The $23.5 million IDC has a base year and four one-year option periods, with an ultimate completion date of December 31, 2025. The contract aims to establish a reliable source of supply for high-volume gabapentin tablets in various strengths and...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide Topiramate tablets over a 1-year base period and four 1-year option periods, for a total potential contract value of $14,134,788.05. The contract will support the VA, Department of Defense, Bureau of Prisons, and Indian Health Service by providing an uninterrupted supply of Topiramate tablets in...
The National Acquisition Center, a civilian agency within the Department of Veterans Affairs, awarded a single-award indefinite delivery contract to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business manufacturer, to provide 6 line items of fluoxetine HCL capsules in various strengths and bottle configurations. The $10,673,128.95 contract has a base year from December 10, 2022 to December 9, 2023, plus four one-year option periods, for an estimated annual requirement of...

The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide an uninterrupted supply of Buspirone HCL tablets in various strengths and bottle configurations. The one-year base contract, with four one-year option periods, has a ceiling value of $18,126,658.75 and will leverage the VA and DoD Pharmaceutical Prime Vendor programs for efficient distribution to government medical facilities.

The IDC aims to fulfill the estimated annual requirements of over 200,000 units of Buspirone HCL tablets across multiple federal agencies, including the VA, DoD, Bureau of Prisons, and Indian Health Service. The solicitation specified requirements such as the exact drug name, unique NDC numbers, and child-resistant closures for bottles of 100 tablets or less. This unrestricted procurement, with no set-asides, was issued under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) to ensure a reliable source of supply for this critical medication.

Generated 8/5/25, 9:43 AM